Human gut microbiota Metagenome
Download from source ↗Dataset overview
Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel disease.
Abstract
The human gut includes plasma cells (PCs) expressing immunoglobulin A1 (IgA1) or IgA2, two structurally distinct IgA subclasses with elusive regulation, function, and reactivity. We show here that intestinal IgA1+ and IgA2+ PCs co-emerged early in life, comparably accumulated somatic mutations, and were enriched within short-lived CD19+ and long-lived CD19- PC subsets, respectively. IgA2+ PCs were extensively clonally related to IgA1+ PCs and a subset of them presumably emerged from IgA1+ precursors. Of note, secretory IgA1 (SIgA1) and SIgA2 dually coated a large fraction of mucus-embedded bacteria, including Akkermansia muciniphila. Disruption of homeostasis by inflammatory bowel disease (IBD) was associated with an increase in actively proliferating IgA1+ plasmablasts, a depletion in long-lived IgA2+ PCs, and increased SIgA1+SIgA2+ gut microbiota. Such increase featured enhanced IgA1 reactivity to pathobionts, including Escherichia coli, combined with depletion of beneficial A. muciniphila. Thus, gut IgA1 and IgA2 emerge from clonally related PCs and show unique changes in both frequency and reactivity in IBD.
Study facts
- Organism
- —
- Platform
- Illumina MiSeq
- Age group
- —
- Disease groups
- —
- Anatomical sites
- —
Data availability
Specific data assets have not been resolved from the source yet — see the source repository below for the full file listing.
Strengths & limitations for reuse
Strengths
- Raw reads are advertised
- Sample counts are documented
Limitations
- Not documented: feature/otu tables are advertised
- Not documented: taxonomic tables are advertised
- Not documented: participant counts are documented
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.paired_end |
True |
subjected to multiplexed sequencing on a MiSeq instrument (Illumina) with the 500 Cycle V2 Kit (2 × 250 bp) Section |
assay.platform |
Illumina MiSeq from source |
ENA instrument_model=Illumina MiSeq Section |
assay.primers_reported |
True |
PCR primers that target bacterial 16S V3 and V4 regions (Table S6) Section |
assay.read_length |
250 |
Paired-end 250 nucleotide reads were filtered using dada2 Section |
assay.sequencing_type |
amplicon_16s |
16S rRNA amplicons from each of these bacterial fractions were generated and sequenced Section |
assay.target_region |
16S V3-V4 |
PCR primers that target bacterial 16S V3 and V4 regions Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.study_design |
cross_sectional inferred |
Fecal samples were collected by the patient at home and brought to the hospital within 24 h and then stored at −80°C until processing. Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.open_access |
True from source |
"isOpenAccess": "Y" Section |
data_assets.pipeline_or_tool_versions |
True |
QIIME2 (v2019.1, [Bolyen et al., 2019]) was used to execute the whole 16S analysis. Section |
data_assets.qc_or_negative_controls_reported |
True |
sheath fluid samples were sequenced and processed to identify putative contaminant operational taxonomic units (OTUs) Section |
data_assets.raw_reads |
True |
Ig gene and 16s RNA sequencing data are publicly available at NCBI’s Sequence Read Archive, accession codes PRJNA596067 and PRJNA902959 Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.number_of_samples |
132 from source |
ENA sample_count=132 Section |
specimens.sample_type |
stool |
profiling fecal bacteria from 6 healthy controls (HC) Section |